Similar articles for PMID: 14676114

Year	Number of Results
1994	1
1995	1
1996	1
1997	3
1998	2
1999	5
2000	3
2001	6
2002	4
2003	19
2004	17
2005	28
2006	26
2007	26
2008	25
2009	16
2010	16
2011	16
2012	17
2013	9
2014	3
2015	5
2016	3
2017	3
2018	3
2019	2
2020	4
2021	3
2022	3
2024	0

1

A Phase II study of weekly irinotecan and capecitabine in patients with previously treated non-small cell lung cancer.

Han JY, Lee DH, Kim HY, Kim EA, Lee JJ, Ju SY, Shin EH, Lee JS. Han JY, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5909-14. Clin Cancer Res. 2003. PMID: 14676114 Clinical Trial.

2

Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma.

Han JY, Lee DH, Lee SY, Park CG, Kim HY, Lee HG, Lee JJ, Kim HT, Lee JS. Han JY, et al. Cancer. 2005 Dec 15;104(12):2759-65. doi: 10.1002/cncr.21563. Cancer. 2005. PMID: 16294344 Free article. Clinical Trial.

3

A phase II trial of docetaxel plus capecitabine in patients with previously treated non-small cell lung cancer.

Lee JJ, Han JY, Lee DH, Kim HY, Chun JH, Lee HG, Yoon SM, Lee SY, Lee JS. Lee JJ, et al. Jpn J Clin Oncol. 2006 Dec;36(12):761-7. doi: 10.1093/jjco/hyl106. Epub 2006 Oct 16. Jpn J Clin Oncol. 2006. PMID: 17043059 Clinical Trial.

4

The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer.

Shin SJ, Ahn JB, Choi HJ, Cho BC, Jeung HC, Rha SY, Chung HC, Roh JK. Shin SJ, et al. Cancer Chemother Pharmacol. 2008 Jan;61(1):75-81. doi: 10.1007/s00280-007-0447-2. Epub 2007 Mar 21. Cancer Chemother Pharmacol. 2008. PMID: 17375304 Clinical Trial.

5

Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.

Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF. Jagasia MH, et al. Clin Cancer Res. 2001 Jan;7(1):68-73. Clin Cancer Res. 2001. PMID: 11205920 Clinical Trial.

6

Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG).

Kentepozidis N, Economopoulou P, Christofyllakis C, Chelis L, Polyzos A, Vardakis N, Koinis F, Vamvakas L, Katsaounis P, Kalbakis K, Nikolaou C, Georgoulias V, Kotsakis A. Kentepozidis N, et al. Clin Transl Oncol. 2017 Mar;19(3):317-325. doi: 10.1007/s12094-016-1532-y. Epub 2016 Aug 4. Clin Transl Oncol. 2017. PMID: 27492015 Clinical Trial.

7

Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402.

Nogami N, Hotta K, Segawa Y, Takigawa N, Hosokawa S, Oze I, Fujii M, Ichihara E, Shibayama T, Tada A, Hamada N, Uno M, Tamaoki A, Kuyama S, Ikeda G, Osawa M, Takata S, Tabata M, Tanimoto M, Kiura K. Nogami N, et al. Acta Oncol. 2012 Jul;51(6):768-73. doi: 10.3109/0284186X.2011.648342. Epub 2012 Jan 27. Acta Oncol. 2012. PMID: 22283472 Clinical Trial.

8

Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study.

Hofheinz RD, Gnad-Vogt U, Wein A, Saussele S, Kreil S, Pilz L, Hehlmann R, Hochhaus A. Hofheinz RD, et al. Anticancer Drugs. 2005 Jan;16(1):39-45. doi: 10.1097/00001813-200501000-00005. Anticancer Drugs. 2005. PMID: 15613902 Clinical Trial.

9

Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.

Cartwright T, Kuefler P, Cohn A, Hyman W, Berger M, Richards D, Vukelja S, Nugent JE, Ruxer RL Jr, Boehm KA, Asmar L. Cartwright T, et al. Clin Colorectal Cancer. 2008 Nov;7(6):390-7. doi: 10.3816/CCC.2008.n.052. Clin Colorectal Cancer. 2008. PMID: 19036692 Clinical Trial.

10

A phase II study of irinotecan plus cisplatin for patients with advanced stage IIIB or IV NSCLC previously treated with nonplatinum-based chemotherapy.

Kim HT, Han JY, Lee DH, Chun JH, Lee HG, Lee JJ, Kim HY, Lee SY, Lee JS. Kim HT, et al. Cancer. 2006 Aug 15;107(4):799-805. doi: 10.1002/cncr.22063. Cancer. 2006. PMID: 16826586 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

234 results

Results by year